Showing results (921-930 of 19,545) with videos related to
Sort By:
Pageof 1,955
BMC Cancer|December 13, 2012
Association of p21 SNPs and risk of cervical cancer among Chinese womenNing Wang, Shizhuo Wang, Qiao Zhang, et al.BMC Cancer|December 13, 2012
"Iron-saturated" bovine lactoferrin improves the chemotherapeutic effects of tamoxifen in the treatment of basal-like breast cancer in miceXueying Sun, Ruohan Jiang, Aneta Przepiorski, et al.BMC Cancer|December 13, 2012
Neural protein gamma-synuclein interacting with androgen receptor promotes human prostate cancer progressionJunyi Chen, Li Jiao, Chuanliang Xu, et al.BMC Cancer|December 14, 2012
Occupational exposure to asbestos and lung cancer in men: evidence from a population-based case-control study in eight Canadian provincesPaul J Villeneuve, Marie-Élise Parent, Shelley A Harris, et al.BMC Cancer|December 14, 2012
Statins and the risk of gastric cancer in diabetes patientsJeeyun Lee, Soo Hyeon Lee, Kyu Yeon Hur, et al.BMC Cancer|January 23, 2013
Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancerFranziska Eckert, Saladin Alloussi, Frank Paulsen, et al.BMC Cancer|January 25, 2013
Potentiation of in vitro and in vivo antitumor efficacy of doxorubicin by cyclin-dependent kinase inhibitor P276-00 in human non-small cell lung cancer cellsMaggie J Rathos, Harshal Khanwalkar, Kavita Joshi, et al.BMC Cancer|December 18, 2012
Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patientsVerena Engelstaedter, Sabine Heublein, Anamur Lan Schumacher, et al.BMC Cancer|December 18, 2012
The STAR trial protocol: a randomised multi-stage phase II/III study of Sunitinib comparing temporary cessation with allowing continuation, at the time of maximal radiological response, in the first-line treatment of locally advanced/metastatic renal cancerFiona J Collinson, Walter M Gregory, Chris McCabe, et al.BMC Cancer|December 19, 2012
Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trialDavid Pérol, Jocelyne Provençal, Anne-Claire Hardy-Bessard, et al.Pageof 1,955